ASIC vs REGN · rev $116.1M vs P/E 14, rev $14.34B
Ategrity Specialty Holdings LLC (ASIC) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Ategrity Specialty Holdings LLC (ASIC) is a insurance - property & casualty company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ASIC revenue for 2025-09-30 was $116.1M. Net income was $23.6M. Revenue was up 14.1% from 2025-06-30 to 2025-09-30. ASIC currently screens at market cap $0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ASIC currently screens at market cap $0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ASIC and REGN stock pages for the full models.
Not investment advice.